With developing technological innovations in the health care sector
comprising biosensors, smartphone apps, lab-on-chip and tech tops,
that offer a nearer association with the patient. Decentralized testing techniques are therefore becoming a catalyst in the
transformation of the health care sector. The main reason that this
type of testing is trending nowadays is because of its access and
quicker results. It can be done closer to the patient, the results
are convenient and quicker to the provider to further rush for the
diagnosis and treatment. Decentralized infectious testing lets faster
clinical decisions at the physician’s clinic, ambulance, and home.
Decentralized testing can make a difference in the treatment of the
patient. As this testing system is portable and moving it to the site
of the patient, increases the chances of the physician, patient and
the care team to have faster results and immediate decision making.
The demand for decentralized testing is increasing due to rising
incidences of infectious diseases in developing countries. The
increasing usage of decentralized testing and technological
innovations with respect to ease of use and faster testing devices
are encouraging the usage of decentralized testing. The decentralized
testing market has professional and patient friendly or
self-monitored testing like food pathogens, hematology, infectious
diseases, coagulation test and urine analysis. Rapid results and
first hand treatment reduces the downstream costs. As the
conventional health care sector shifts to modern health care, more
services can be presented to the patients at the decentralized
testing of the patient.
Know the Trends of Decentralized Infectious Disease Testing at:
http://bit.ly/2cbgqF6
The factors driving the trend of decentralized infectious disease
testing include increasing trend of patient centric care,
technological innovations, shortage of laboratory staff, increasing
aging population, and rising incidences of infectious diseases. Even
the diagnostic laboratories are also transforming on the basis of
this format, where complex tests are performed in core labs and
decentralized testing is performed in clinics, outpatient clinics or
at patients home. This improves quality of care and access of care to
the geriatric population. Advancements in the technology have been
made such that it can be performed even by moderately trained staff.
Many tests require labs for testing but now can be performed at the
point of care. Another factor which drives the decentralized
infectious disease testing market is the lack of trained staff in the
laboratories. With less trained laboratory staff, drives the labs
towards automated testing procedures and towards minimal user
interaction systems. Thus, factors such as reduced sample volume,
less specimen processing, shorter hospital stay, optimized medicine
treatment and less post-operative care time support the growth of
decentralized infectious disease testing market.
The decentralized infectious disease testing gives results for over
75 type of infectious diseases across varied testing platforms which
include advanced technology laboratory equipment along with rapid
diagnostic tests that can provide results for individual patients in
less than or equal to 5 minutes. Infectious diseases such as malaria,
measles, mumps, rubella, herpes simplex virus, cytomegalovirus,
dengue fever, HIV and many more, can be detected through
decentralized infectious disease testing procedures.
Briefly, North America has more options and a bigger share in the
decentralized infectious disease testing market followed by Europe.
With improved infrastructure and increasing awareness the global
decentralized infectious disease testing market will have a boost in
emerging countries of Asia Pacific. The prominent players having
presence in the global decentralized infectious disease testing
market are Becton-Dickinson and Company, Abbott Laboratories, Beckman
Coulter, Inc., Siemens Medical Solutions, Nipro Diagnostics and
Johnson & Johnson.
No comments:
Post a Comment